STOP THE WAR! Let’s support Ukraine Together

Isleworth Healthcare (ISLE) to Combine with Cytovia Therapeutics in $367M Deal

Isleworth Healthcare (ISLE) to Combine with Cytovia Therapeutics in $367M Deal

Isleworth (NASDAQ:ISLE) has entered into a definitive agreement to combine with biopharmaceutical company Cytovia at an enterprise value of $367 million. The Aventura, Florida-based company is working to develop a range of therapies to treat liver cancer with modified natural killer cells. The combined company is expected to trade on the Nasdaq under the symbol
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.